quinuclidines has been researched along with docetaxel anhydrous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trissel, LA; Xu, QA | 1 |
| Alfredsson, J; Björklund, U; Bykov, VJ; Byström, S; Fransson, Å; Gullbo, J; Hallberg, A; Mohell, N; Uustalu, M; Wiman, KG | 1 |
2 other study(ies) available for quinuclidines and docetaxel anhydrous
| Article | Year |
|---|---|
Stability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administration.
Topics: Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Docetaxel; Drug Combinations; Drug Stability; Injections, Intravenous; Isoquinolines; Paclitaxel; Palonosetron; Quinuclidines; Serotonin Antagonists; Taxoids | 2004 |
APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cells, Cultured; Cisplatin; Deoxycytidine; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Activation; Female; Gemcitabine; Glutathione; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Protein Folding; Quinuclidines; Random Allocation; Taxoids; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2015 |